CytomX Therapeutics, Inc.
No trades
No trades
Fundamentals and stats
The company's current financial position
Total assets for Q1 26 are 359.36 M USD, 135.65% more than in Q4 25. And total liabilities decreased by 26.32% in Q1 26 to 39.41 M USD.
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total assets
Total liabilities
MetricsCurrency: USD
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025